- Home
- From the CEO
-
- Projects
- Breaking barriers and building careers
- Engaging men in family life
- Creating clothes, jobs and community
- Detecting multidrug-resistant tuberculosis
- Building community and reducing HIV stigma
- Supporting mental health and building resilience
- Providing education amid conflict
- Ensuring children’s growth and development
- Helping communities thrive
- Supporting healthy behaviors through entertainment
- Cultivating social change
- Developing young climate-action leaders
- Financials
- Funders
- Global Reach
Previous project
Photo credit: Masum Vohidov for FHI 360
Makhmatlatif Karimov, diagnostics and laboratory advisor for the USAID End TB Tajikistan Activity — which FHI 360 implements — and Lola Sharipova, laboratory technician for the Kulob Regional TB Center Laboratory, check mycobacteria growth indicator tubes while conducting a rapid tuberculosis (TB) testing network assessment in Kulob, Tajikistan.
Tajikistan is on the World Health Organization’s list of 30 high-burden multidrug-resistant TB countries; multidrug-resistant TB does not respond to the two most effective antibiotics.
“Rapid and accurate diagnosis, followed by prompt treatment and completed therapy, is essential for the effective control of TB,” says Makhmatlatif. All positive results are sent to the national laboratory, which determines what strain a person has and whether it is multidrug-resistant. The national program then uses the data to determine the correct treatment regimen.
“Rapid and accurate diagnosis, followed by prompt treatment and completed therapy, is essential for the effective control of TB.”
